Table 3.
Annual direct medical cost (DMC) of Alzheimer’s disease (AD) in Iran
| Type of cost |
Mild AD
|
Moderate AD
|
Severe AD
|
|||
|---|---|---|---|---|---|---|
| Mean ± SD | % | Mean ± SD | % | Mean ± SD | % | |
| Medicine (USD) | 62 ± 43 | 36.0 | 85 ± 43 | 39.0 | 110 ± 56 | 15.5 |
| Lab test (USD) | 6 ± 9 | 4.0 | 0 | 0 | 0 | 0 |
| Diagnostic services (USD) | 43 ± 39 | 25.0 | 0 | 0 | 20 ± 9 | 3.0 |
| Consultation and visit (USD) | 60 ± 17 | 35.0 | 58 ± 5 | 26.0 | 58 ± 5 | 8.5 |
| Rehabilitation interventions (USD) | 0 | 0 | 76 ± 36 | 35.0 | 514 ± 231 | 73.0 |
| Total DMC (USD) | 171 ± 81 | 100 | 219 ± 168 | 100 | 702 ± 172 | 100 |
SD: Standard deviation; AD: Alzheimer’s disease; DMC: Direct medical cost